Stem Cells Group to Host Regenerative Medicine Symposium at the University of Miami
ISSCA will partner with SIISDET at the October 2019 event, which will share valuable information with physicians regarding recent breakthroughs in regenerative medicine
MIAMI LAKES, Florida—The International Society for Stem Cells Application (ISSCA), a multi-disciplinary community of scientists and physicians collaborating to treat diseases and lessen human suffering through science, technology, and regenerative medicine, will co-host a symposium in October 2019 with the Sociedad Internacional en Investigación, Salud, Desarrollo Empresarial (SIISDET). The event will be held at the University of Miami on October 22-24, 2019 in the West Ballroom of the Shalala Student Complex.
The Miami symposium will feature educational sessions and product information and demonstrations aimed at doctors looking to incorporate regenerative medicine into their practices. Industry experts will be on hand to share the latest information on the newest compounds in the allogeneic stem cells market, including exosomes, amniotic fluid compounds, and cord blood products.
Allogeneic compounds have gained growing popularity in regenerative medicine due to their increased safety and treatment efficacy. With this in mind, ISSCA representatives will be on hand to give physicians the opportunity to learn more about these popular treatment solutions and how they can be utilized in their practices.
“We are pleased to be able to partner with SIISDET to be able to offer this exciting symposium at the University of Miami,” said Benito Novas, CEO of ISSCA. “We are continually seeking ways to bring the latest advances in regenerative medicine to physicians across the globe. Our Miami symposium will play a critical role in accomplishing this by helping physicians expand their knowledge bases and explore new treatment options in regenerative medicine.”
In addition to educational sessions, the Miami symposium will provide networking and social opportunities for those in attendance. Events on the agenda include an optional boat trip around Miami on the Miami River and a Columbian Day celebration offering live music and Colombian cuisine to symposium attendees.
To learn more about ISSCA’s Miami symposium or to register for the event, visit https://www.issca.us/.
- Published in Press Releases
ISSCA Reaches Agreement with Belgium’s Churchill Aesthetic Center
The innovative new center will provide training in regenerative medicine for doctors located in Belgium and France.
MIAMI LAKES, Florida—The International Society for Stem Cell Application (ISSCA), a multi-disciplinary community of scientists and physicians collaborating to treat diseases and lessen human suffering through science, technology, and regenerative medicine, has signed an agreement with Belgium’s Churchill Aesthetic Center. Beginning in July 2019, the center will offer stem cells certification programming for physicians in Belgium and France looking to add regenerative medicine treatment options to their practices.
ISSCA’s Belgian partnership builds on the group’s mission to reach new markets and expand regenerative medicine treatment options to physicians across the globe who want to offer new treatment options to their patients suffering from degenerative diseases and sports injuries. In its most recent clinic openings and partnerships, ISSCA has primarily focused on expanding efforts in the Middle East, US, and Latin America. The group recently set its sights on European expansion, with the partnership in Belgium serving as its second center in Europe, with the other located in Barcelona.
The cutting-edge facility will be equipped by Adimarket, LLC, a subsidiary of the Global Stem Cells Group. Adimarket will outfit the center with equipment and supplies designed to not only teach doctors about the latest protocols in regenerative medicine but also to treat patients suffering from degenerative diseases and sports injuries. Physicians training at the facility will have access to the proven expertise of ISSCA’s global network and training protocols.
“We look forward to ISSCA’s exciting new partnership with Belgium’s Churchill Aesthetic Center and the possibilities it brings in delivering safe and effective regenerative medicine treatment options to more patients across the globe,” said Benito Novas, CEO of the Global Stem Cells Group. “This partnership will help us prepare more physicians to deliver cutting edge treatment options to their patients that help alleviate suffering while also achieving our mission of expanding our global reach.”
To learn more about Churchill Aesthetic Center, visit https://www.churchill-aesthetic-center.be/. To learn more about ISSCA, visit https://issca.us/.
- Published in Press Releases
Benito Novas, Global Stem Cells Group CEO Announces Opening of New Stem Cell Center in Valencia, Spain
The new center will continue the Global Stem Cells Group’s mission to expand access to stem cell therapies and training to physicians across the globe.
MIAMI LAKES, Florida—A new Stem Cell Center is set to open its doors in Spain. Benito Novas, CEO of the Global Stem Cells Group (GSCG), a multi-disciplinary community of scientists and physicians collaborating to treat diseases and lessen human suffering through science, technology, and regenerative medicine, has announced the opening of the group’s Valencia, Spain center. The new clinic will be the group’s third operation in Spain and the fourth in Europe.
The Global Stem Cells Group’s Valencia center joins the already existing centers in , which include locations in Bruselas, Madrid, and Barcelona. With the opening of the new center, the GSCG will boast 41 such locations across the globe.
Novas noted that the group has been focusing its efforts on opening its cutting-edge Stem Cell Centers in Europe, in part due to the group’s recognition that regenerative medicine is a fast-growing field across the continent.
“We are pleased to be able to open the doors on a new Stem Cells Center in Europe,” noted Novas. “The GSCG is continually exploring opportunities to deliver new stem-cell based treatment options to patients across Europe, and the Valencia center gives us the opportunity to do this while meeting our strategic mission to expand our presence in Europe.”
In opening the new center, the GSCG has signed an agreement with Dra. Laura Maria Caicedo, medical director of the Instituto Valenciano MEDEC (https://medec.es/conoce-medec/#equipoMedico). Dr. Caicedo is a specialist on hair loss with an interest in delivering stem cell based treatments to her patients and others in Valencia.
“I am thrilled to lead the efforts at the Stem Cell Center in Valencia,” said Dra. Caicedo. “I am looking forward to utilizing cutting-edge therapy options based in stem cell science to help treat patients suffering from hair loss. Additionally, the opportunity is an exciting one given the Global Stem Cells Group’s excellent reputation and stature as the longest-standing and most respected stem cells network. I’m looking forward to learning from other physicians in the network across the globe and sharing my expertise with other practitioners in regenerative medicine.”
The GSCG will provide the Valencia center with the newest and most effective marketing tools in the field to help the franchise increase its performance in recruiting new patients.
Marketing support is one of the many benefits of joining the GSCG’s expanding global network of clinics. Being part of the group’s network gives physicians access to other experts within the its global network, add to their practice the newest regenerative medicine protocols, and have access to a proven marketing strategy developed by GSCG.
To learn more about the Global Stem Cells Group, visit http://www.stemcellsgroup.com/.
.
- Published in Press Releases
ISSCA Set to Host Regenerative Medicine Symposium in Buenos Aires
The global group will hold its 6th International Regenerative Medicine Symposium in October 2019.
MIAMI LAKES, Florida—The International Society for Stem Cell Application (ISSCA), a multi-disciplinary community of scientists and physicians collaborating to treat diseases and lessen human suffering through science, technology, and regenerative medicine, has announced its 6th annual International Regenerative Medicine Symposium in Buenos Aires. The event will attract physicians from across the globe and will be held on October 12, 2019 in Buenos Aires, Argentina at the Hotel Panamericano.
The past five years of the ISSCA sponsored event have been a global success. This year’s meeting will feature educational sessions and product information and demonstrations, with a special focused placed on the newest compounds in the allogeneic stem cells market, including exosomes, amniotic fluid compounds, and cord blood products. With allogeneic compounds growing in popularity, safety, and treatment efficacy, ISSCA will give physicians the opportunity to learn more about them and how they can be incorporated into their practices.
A number of experts within the field of regenerative medicine are confirmed for the event and include.
• Dra. Maritza Novas, Chief of I&D, Global Stem Cells Group USA
• Dr. Leopoldo Paradas, President of Asociación Chilena de Ingeniería Tisular
• Dr. Matias Fernandez Vina Argentinian Cardiologist
“We are pleased to be hosting our popular International Regenerative Medicine Symposium for a sixth year,” said Benito Novas, CEO of ISSCA. “Each year our symposium focuses on critical topics and exciting breakthroughs in the field of regenerative medicine, and this year is no different as we seek to retain our position as a vanguard in the field.”
Physicians interested in registering for or learning more about the Buenos Aires symposium may visit https://www.issca.us/.
- Published in Press Releases
- 1
- 2